⌘K

Home/Filings/4/0001213900-19-012884

4//SEC Filing

Ludwig Dale L. 4

Accession 0001213900-19-012884

CIK 0001388320other

View on SEC.gov Company Profile

Filed

Jul 15, 8:00 PM ET

Accepted

Jul 16, 5:13 PM ET

Size

5.4 KB

Accession

0001213900-19-012884

Insider Transaction Report

Form 4

Period: 2019-07-12

Actinium Pharmaceuticals, Inc.ATNM

Chief Scientific Officer

Transactions

Award
Options to purchase common stock
2019-07-12$0.23/sh+400,000$92,800→ 400,000 total
Exercise: $0.23From: 2019-07-12Exp: 2029-07-12→ Common Stock (400,000 underlying)

Footnotes (1)

[F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Actinium Pharmaceuticals, Inc.

CIK 0001388320

Entity typeother

Related Parties

1

filerCIK 0001727406

Filing Metadata

Form type: 4
Filed: Jul 15, 8:00 PM ET
Accepted: Jul 16, 5:13 PM ET
Size: 5.4 KB

View on SEC.gov